Baxion
Screening
Tags
Alerts
Theme
Immunome Inc.
IMNM
·
NASDAQ
·
$21.91
Share Price as of 11/2
·
$2B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/11/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/03/26
10-Q
Q3 ended 09/30/25
11/06/25
10-Q
Q2 ended 06/30/25
08/06/25
Disclosures
Filter
8-K
Current report
10/05/26
8-K
Current report
08/11/26
8-K
Current report
06/12/26
8-K
Current report
05/12/26
8-K
Current report
03/03/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
08/11/26
S-8
Registration of securities for employees
03/03/26
424B5
Prospectus supplement
12/17/25
424B5
Prospectus supplement
12/15/25
S-8
Registration of securities for employees
03/19/25
Proxies
Filter
DEF 14A
Definitive proxy
04/24/26
DEFA14A
Additional proxy materials
04/24/26
DEF 14A
Definitive proxy
04/24/25
DEFA14A
Additional proxy materials
04/24/25
DEF 14A
Definitive proxy
04/26/24
Ownership
Filter
SC 13G
Beneficial ownership
10/30/26
Form 4
Insider transaction
09/15/26
144
Proposed sale of securities
09/11/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Other
Filter
ARS
Annual report to shareholders
04/24/26
ARS
Annual report to shareholders
04/24/25
ARS
Annual report to shareholders
04/26/24
EFFECT
Request for effectiveness
11/27/23
CORRESP
Correspondence with the SEC
11/22/23
Latest Filings
Filter
8-K
Current report
10/05/26
10-Q
Q2 ended 06/30/26
08/11/26
8-K
Current report
08/11/26
S-8
Registration of securities for employees
08/11/26
8-K
Current report
06/12/26
Ownership
Filter
SC 13G
Beneficial ownership
10/30/26
Form 4
Insider transaction
09/15/26
144
Proposed sale of securities
09/11/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26